Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05322460
Other study ID # UPNA-CUMACA-B2022
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 2023
Est. completion date June 2024

Study information

Verified date April 2022
Source Fundacion Miguel Servet
Contact Cristina García-Vivar, PhD
Phone +34948166150
Email cristina.garciavivar@unavarra.es
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The number of breast cancer survivors is growing. More cured women are becoming long-term survivors of breast cancer (LS-BC) at least 5 years after diagnosis and after treatment has been completed. Some of these LS-BC return to daily life without any problems; however, in many cases, they experience and have to deal with physical sequelae (chronic fatigue, pain, etc.) psychological sequelae (anxiety, depression, fear of recurrence, etc.) and social sequelae (altered interpersonal relationships, difficulty in returning to work, etc.). For many LS-BC, these health problems are not being met by health professionals. Thus there is a need to promote greater continuity and coordination between specialized oncology care and primary health care in order to enhance specific follow-up of these women in the community. However, the role of the primary health care team in the provision of care in the long-term cancer survival is not clearly defined and few actions have been aimed at improving care activities, standardizing procedures and protocols, developing documentation and registries and updating the training of health care professionals. Therefore, this study aim to design, implement, and evaluate a web based tailored intervention, using artificial intelligence, to improve the quality of life of long-term breast cancer survivors, and self-efficacy for the management of late sequelae from primary care.


Description:

Hypothesis: A web-based tailored intervention, based on the prevention and management of physical and psychosocial late effects due to cancer treatment and aimed at improving the coexistence of long-term breast cancer, will be more effective in improving quality of life and self-efficacy for the management of late sequelae from Primary Care, than conventional care offered in Primary Care. Aim: To design, implement and evaluate the effectiveness of a web-based tailored intervention, based on artificial intelligence, to improve the quality of life of long-term survivors of breast cancer and self-efficacy for the management of late sequelae from Primary Healthcare. Methodology: Randomized controlled trial (following the Medical Research Council methodological framework). Phase I. Design of a personalized digital intervention based on the results of a review of the available evidence on the needs of long-term survivors (LS-BC) of breast cancer and agreed with a panel of experts. It will be designed in web/mobile application format. The use of algorithms will allow the personalization of the contents according to the needs. Phase II. Piloting: Pre-experimental design pretest-postest with one group, by means of a convenience sampling with LS-BC women, who meet the selection criteria. The collection of sociodemographic and clinical data, as well as the variables under study; quality of life (QOL-BC), self-efficacy in the management of cancer sequelae (Self-Efficacy for Managing Chronic Disease). The participants will use a web application and will test the usability and functionality. Phase III. Implementation of the intervention: Randomized controlled trial. Random sampling of LS-BC and random assignment to the intervention group (CUMACA-M program) or control group (standard care). A protocol will be designed that allows the collection of data and variables (Phase II) and satisfaction with the intervention (CSQ-8), at pre-intervention, and at 3, 6 and 9 months.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 182
Est. completion date June 2024
Est. primary completion date June 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - having been diagnosed with breast cancer - having completed active oncological treatments (chemotherapy and/or radiotherapy) in a period of time greater than five years, - be free of disease at the time of data collection - be a woman and over 18 years of age - have knowledge of Internet use. Exclusion Criteria: - Women with a diagnosis of cancer other than breast cancer - Recurrence of cancer or metastasis that causes a new treatment - Being in active treatment for recurrence or new cancer - Being a man

Study Design


Related Conditions & MeSH terms

  • Long-term Effects of Cancer Treatment
  • Long-term Effects Secondary to Cancer Therapy in Adults

Intervention

Other:
CUMACA-M Program
The CUMACA-M Program will focus on a web-based tailored intervention, using artificial intelligence, for Long-Term Survivors of Breast Cancer. It will be structured into modules related to the specific needs of LS-BS, including physical, psychological, and social needs

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Cristina García-Vivar Instituto de Salud Carlos III

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of life Cancer Survivor (QOL-CS) The QOL-CS, Spanish version (Ferrell B, Hassey-Dow K, Grant M. Quality of Life Patient/Cancer Survivor Version (QOL-CS) [Internet]. Measurement Instrument Database for the Social Science. 2012). Scale specific for cancer survivor. Likert-type scale with 10 options (1 extremely poor and 10 excellent) with 41 items that measure the four domains of quality of life: physical, psychological, social and spiritual well-being. Changes from baseline, 3-months, 6 months, and 9 month
Primary Self-Efficacy for Managing Chronic Disease The Self-Efficacy for Managing Chronic Disease- 6-Item Scale (SEMCD-6) (Ritter PL, Lorig K. The English and Spanish Self-Efficacy to Manage Chronic Disease Scale measures were validated using multiple studies. J Clin Epidemiol. 2014; 67(11): 1265-73). The scale is structured in 6 items related to symptom control, role performance, emotional state and communication with health professionals Changes from baseline, 3-months, 6 months, and 9 month
Primary Sociodemographic data of LS-BC Sociodemographic data of the LS-BC (age, sex, marital status, educational level, employment status) will be collected by means of an ad hoc questionnaire at the beginning of the intervention. Baseline
Secondary Client Satisfaction Questionnaire (CSQ-8) The satisfaction with the CUMACA-M Program will be measured using the Spanish version of the Client Satisfaction Questionnaire (CSQ-8) (Attkisson CC, Greenfield TK. The UCSF Client Satisfaction Scales: I. The Client Satisfaction Questionnaire-8. In Maruish M (Ed). 2004). This scale is structured into 8 items with has five response options (from very dissatisfied to very satisfied). 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT00956475 - Quality of Life in Younger Leukemia and Lymphoma Survivors Phase 1
Active, not recruiting NCT01141231 - Acupuncture in Treating Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer Phase 3
Completed NCT00410579 - Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers N/A
Completed NCT00755313 - Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer N/A
Recruiting NCT02468882 - Does Watercress Intake Have an Impact on Cancer Patients Outcomes: a Longitudinal Trial Phase 3
Completed NCT00662103 - Aerobic Exercise, Resistance Exercise, or Flexibility and Relaxation Training in Inactive Older Female Breast Cancer Survivors N/A
Recruiting NCT04265638 - Exercise Intervention in Adolescent and Young Adult Cancer Survivors N/A
Completed NCT00415025 - Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer N/A
Active, not recruiting NCT00632983 - Active Surveillance, Radical Prostatectomy, or Radiation Therapy in Treating Patients With Localized Prostate Cancer Phase 3
Terminated NCT00909662 - Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers N/A
Recruiting NCT01087268 - Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer Phase 3
Active, not recruiting NCT00400907 - Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9 N/A
Completed NCT00599989 - Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer N/A
Withdrawn NCT00402935 - Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer N/A
Completed NCT00389584 - Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors Phase 1/Phase 2
Completed NCT00743236 - Warm Ischemia or Cold Ischemia During Surgery in Treating Patients With Stage I Kidney Cancer N/A
Completed NCT00799461 - Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications Phase 3
Terminated NCT03172988 - Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer Surgery Phase 4
Completed NCT00410618 - Neurological Effects of Chemotherapy and Radiation Therapy in Patients With Colon Cancer